JBM (Healthcare) is a Hong Kong-based company that markets and distributes branded healthcare products with product footprint across Greater China, Southeast Asia and other select countries. Its products divided into two categories which include consumer healthcare products and proprietary Chinese medicines. As of March 31, 2020, its healthcare products consisted more than 1,700 products (including more than 700 single and combo formula CCMG products).

The Group operate a vertically integrated business encompassing brand management and marketing, sourcing and representation of third-party brand products, development and manufacturing of own brand products, and sales and distribution. As at March 31, 2020, it carried 11 principal third-party brands, the majority of which were sourced from Europe, including consumer healthcare products imported from reputable European GMP-accredited, SO-certified or SGS-certified manufacturers.

It adopts a hybrid of sales and distribution models tailored for different products and geographic markets. In Hong Kong, it sells its products both directly and indirectly (through its Hong Kong Distributor and its trading company customers) to major modern trade chain stores, registered pharmacies and drug stores, as well as corporate clients, hospitals and clinics, and end consumers (through online platforms). In addition, it sells CCMG products to more than 3,000 Chinese medicine practitioners, and from time to time, to non-profit organizations. Outside of Hong Kong, it sells selected products to Mainaland China, Macau, Taiwan, and select countries in Southeast Asia, Europe, North America and the Caribbean Islands, primarily through distributorship and wholesaling arrangements.

Apart from its own brand CCMG products which are outsourced to GMP-accredited third-party manufacturers for production, it manufactures most of the products under its principal own brands in-house. Its manufacturing facilities are located in Hong Kong and comprise a PIC/S GMP-accredited manufacturing facility for the production of its Ho Chai Kung branded products; two GMP-accredited manufacturing facilities mainly for the production of Po Chai Pills and Flying Eagle Woodlok Oil; and other manufacturing facilities primarily used for the production of certain other proprietary Chinese medicines.